This spring the 11 year-old brown glass furnace will be replaced by a new one.
The furnace is constantly filled with 200 tons of molten glass. It is made of a fireproof material which gradually erodes over time as a result of constant exposure to molten glass at temperatures of up to 1600 degrees Centigrade, and the chambers also get dusty, so it has to be replaced every 10 to 11 years.
Despite the furnace project, Gerresheimer’s customers can count on punctual and reliable deliveries because the Gerresheimer Group has eight production plants for molded glass around the world. Three of them are in Germany - in Essen, Lohr and Tettau.
Gerresheimer Essen specializes in the production of glass articles for the pharmaceutical industry. That’s why all production lines have clean room technology and advanced production and inspection equipment that is certified as compliant with all the relevant standards. Customers not only expect first-rate glass, but also innovativeness and excellent results. In order to satisfy these discerning requirements and sustain its leadership, Gerresheimer Essen uses state-of-the-art production technology and employs highly qualified production staff who receive regular further training.
The plant manufactures syrup bottles, molded bottles, droppers, tablet jars, cream jars, injection vials and infusion bottles for the pharmaceutical industry. The cataloged product range currently includes several hundred products. Custom-made products are also manufactured.
About Gerresheimer
Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.
Our Group realizes revenues of more than one billion euros and has around 11,000 employees at 47 locations in Europe, North and South America and Asia. We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.